Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04566393 |
|---|---|
| Brief Title: | Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies |
| First Submitted : | September 17, 2020 |
| First Submitted that Met QC Criteria : | September 21, 2020 |
| First Posted : | September 28, 2020 |
| Last Update Submitted that Met QC Criteria : | February 13, 2023 |
| Last Update Posted : | February 14, 2023 |